沙利文发布《2026全球合成生物学行业发展蓝皮书》
Frost & Sullivan Releases the " 2026 Global Synthetic Biology Industry Development Blue Book "
当前，合成生物学已从实验室的前沿探索，跃升为国家战略博弈的核心战场。2026年政府工作报告明确提出培育壮大新兴产业和未来产业，推动生物制造成为新的经济增长点。这意味着，合成生物与生物制造已不再是单纯的技术议题，而是承载着国家安全（供应链自主可控）、气候议程（双碳/零碳）与经济增量（新质生产力）三重使命的战略交汇点。
蓝皮书将围绕合成生物学的战略定义与产业意义、关键技术演进与创新突破、产业链全景图谱与价值链拆解、全球国别、区域对标与监管框架、融资逻辑、核心挑战与未来趋势等展开，并将建立起一套超越单一区域视角、兼具全球纵深与全产业链覆盖的研究框架，通过对中国、美国、欧盟、中东及“一带一路”沿线核心市场的深入研判，结合跨国监管政策的系统比较，运用产业链全景图谱、国别/区域对标及监管-技术-商业三重分析透镜，有效规避了行业泛化认知误区，为企业战略决策者与投资机构提供了具备跨区域比较价值与产业参考意义的深度洞察。
Here is the English translation:
Currently, synthetic biology has evolved from a frontier laboratory exploration into a core battleground for national strategic competition. The 2026 Government Work Report explicitly calls for cultivating and expanding emerging industries and future industries, promoting biomanufacturing as a new economic growth driver. This means that synthetic biology and biomanufacturing are no longer merely technical issues; they have become a strategic convergence point bearing threefold missions: national security (supply chain self-sufficiency), climate agenda (dual carbon / net-zero carbon goals), and economic growth (new quality productive forces).
This Blue Book will cover the strategic definition and industrial significance of synthetic biology, key technology evolution and innovation breakthroughs, panoramic mapping of the industry chain and value chain decomposition, global country and regional benchmarking with regulatory frameworks, financing logic, core challenges, and future trends. It establishes a research framework that transcends single-region perspectives, integrating global depth and full-industry-chain coverage. Through in-depth analysis of core markets in China, the United States, the European Union, the Middle East, and key Belt and Road Initiative countries, combined with systematic comparisons of cross-border regulatory policies, and applying a triple analytical lens—industry chain panorama, country/regional benchmarking, and regulation-technology-business assessment—it effectively avoids common cognitive biases in the industry. The result provides enterprise strategists and investment institutions with deep insights that offer cross-regional comparative value and industrial reference significance.
点击以下链接，查看完整版报告：
如果您对全球合成生物学发展有进一步的研究需求，请联系我们：
沙利文 毛先生
E-mail: fred.mao@frostchina.com
